环γ-聚谷氨酸涂层的双重响应性载阿霉素纳米胶束及其抗肿瘤效应
批准号:
81974496
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
张黎明
依托单位:
学科分类:
海洋药物
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
张黎明
中文摘要
常用肿瘤化疗药物水溶性低、稳定性差、体内循环时间短、缺乏肿瘤靶向性,影响治疗效果,甚至引起严重毒副作用。纳米载体可以增强药物的肿瘤靶向性,提升药物稳定性并延缓药物释放。我们从水母刺丝囊分离鉴定了一组全新小分子环γ-聚谷氨酸(cyclo-γ-PGA),与链状γ-聚谷氨酸同属聚阴离子类多肽分子,但又具有环肽结构,性能更加稳定;还以光敏剂原卟啉和含二硫键的硫辛酸为疏水基团,聚乙二醇单甲醚为亲水基团,设计制备了双重响应性纳米胶束mPEG-LA-PpIX。本项目拟进一步制备cyclo-γ-PGA涂层的载阿霉素纳米胶束mPEG-LA-PpIX-DOX@cyclo-γ-PGA,阐明cyclo-γ-PGA作为生物涂层在提升纳米胶束稳定性及利用γ-谷氨酰转肽酶介导的内吞途径增加细胞对胶束摄取等方面的优势;同时明确该纳米胶束的还原/光刺激双重响应性能及其体内外抗肿瘤效应,为肿瘤化疗药物输送体系研究提供新思路。
英文摘要
Common cancer chemotherapeutic agents have poor water-solubility, chemical instability and short blood circulation time, and lack tumor specificity, thus limiting their therapeutic effects and even causing serious side effects. Fortunately, the fast development of nanoscale transport systems for chemotherapeutic drugs based on carrier materials could help to enhance the targeting capability and stability of the drugs and prolong their release time. We have recently isolated and identified a novel group of small cyclopolypeptides, cyclo-gamma-polyglutamic acid (cyclo-γ-PGA), from the jellyfish nematocysts, which belong to polyanionic polypeptides just like the normal gamma-polyglutamic acid peptide chains but with a stabler cyclic peptide backbone. And we have also developed the dual-responsive nanomicelles – mPEG-LA-PpIX, using photosensitizer protoporphyrin (PpIX) and disulfide bond-containing lipoic acid (LA) as the hydrophobic groups and polyethylene glycol methyl ether (mPEG) as the hydrophilic groups. Furthermore, this study aims to synthesize cyclo-γ-polyglutamic acid-coated nanomicelles loaded doxorubicin – mPEG-LA-PpIX-DOX@cyclo-γ-PGA for elucidating the superiority of cyclo-γ-PGA as coating material in improving the stability of nanomicelles and enhancing the uptake of micelles by cells through gamma-glutamyl transpeptidase mediated endocytosis pathway, and it is expected to confirm the reduction/light dual-responsive properties of these nanomicelles and prove their antitumor effects in vitro and in vivo. The results will shed new light on the research of drug delivery systems for cancer chemotherapy.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.1186/s12951-023-02039-2
发表时间:
2023-08-07
期刊:
JOURNAL OF NANOBIOTECHNOLOGY
影响因子:
10.2
作者:
[Zou, Shuaijun, Wang, Qianqian, He, Qian, Liu, Guoyan, Song, Juxingsi, Li, Jie, Wang, Fan, Huang, Yichao, Hu, Yanan, Zhou, Dayuan, Lv, Yongfei, Zhu, Yuanjie, Wang, Beilei, Zhang, Liming]
通讯作者:
Zhang, Liming
DOI:
10.1039/d1bm00713k
发表时间:
2021-08
期刊:
Biomaterials science
影响因子:
6.6
作者:
[Chao Wang;Beilei Wang;Shuaijun Zou;Bo Wang;Guoyan Liu;Fuhai Zhang;Qianqian Wang;Qian He;Liming Zhang]
通讯作者:
Chao Wang;Beilei Wang;Shuaijun Zou;Bo Wang;Guoyan Liu;Fuhai Zhang;Qianqian Wang;Qian He;Liming Zhang
Cell membrane-coated nanoparticles: research advances
细胞膜包裹的纳米粒子:研究进展
DOI:
10.2217/nnm-2019-0388
发表时间:
2020
期刊:
Nanomedicine
影响因子:
5.5
作者:
[Shuaijun Zou, Beilei Wang, Chao Wang, Qianqian Wang, Liming Zhang]
通讯作者:
Liming Zhang
DOI:
10.1016/j.giant.2023.100213
发表时间:
2023-12-02
期刊:
GIANT
影响因子:
7
作者:
[Zou,Shuaijun, Wang,Qianqian, Zhang,Liming]
通讯作者:
Zhang,Liming
重组发形霞水母多肽生长因子Cc-GRN-1的生物学活性与作用机制
-
批准号:81673348
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张黎明
-
依托单位:
水母毒素肾脏毒性蛋白分离及其通过损伤线粒体引起肾小管上皮细胞死亡的作用机制
-
批准号:81370833
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:张黎明
-
依托单位:
发形霞水母毒素心血管活性组分定向分离及其作用机理研究
-
批准号:41176126
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2011
-
负责人:张黎明
-
依托单位:
国内基金
海外基金